Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

104.8K
Overview
104.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.

Cancer prevention research (Philadelphia, Pa.)·2026
Same author

Maintenance Pemetrexed/Pembrolizumab Versus Pembrolizumab in Non-Small Cell Lung Cancer: A Propensity Score-Weighted Analysis.

JCO oncology practice·2026
Same author

Spatially resolved single-cell analyses of human meningioma identify novel cell states influencing tumor microenvironment and progression.

Nature genetics·2026
Same author

Deep learning for H&E-based meningioma molecular classification and outcome prediction: a retrospective cohort study.

The Lancet. Digital health·2026
Same author

Deep survival learning for prognosis prediction in non-metastatic castration-resistant prostate cancer.

Health informatics journal·2026
Same author

Modern Molecular Profiling Recontextualizes the NRG/RTOG 0539 Trial and Reveals Hidden High-Risk and Radiotherapy Resistant Meningiomas.

Neuro-oncology·2026
Same journal

Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101.

JCO clinical cancer informatics·2026
Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026
Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026
Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026
Same journal

Foundation Model-Driven Regions of Interest Classification and Renaming in Cancer Radiotherapy: A Customizable, Retraining-Free Workflow Across Institutions.

JCO clinical cancer informatics·2026
Same journal

Announcing a New Article Type in <i>JCO Clinical Cancer Informatics</i>: The Resource Report.

JCO clinical cancer informatics·2026
See all related articles

Related Experiment Video

Updated: Sep 14, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K

Using Open-Source Large Language Models to Identify Access to Germline Genetic Testing in Veterans With Breast Cancer

Chunyang Li1,2, Michael Stringer2, Vikas Patil1,2

  • 1George E. Wahlen Veterans Affairs Medical Center, Salt Lake City, UT.

JCO Clinical Cancer Informatics
|July 22, 2025
PubMed
Summary
This summary is machine-generated.

Large language models (LLMs) can effectively identify germline genetic testing access in breast cancer patients from clinical notes. This technology shows promise for improving healthcare quality and efficiency while protecting sensitive patient data.

More Related Videos

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.4K
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
11:20

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

11.0K

Related Experiment Videos

Last Updated: Sep 14, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.1K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.4K
Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology
11:20

Simple and Rapid Method to Obtain High-quality Tumor DNA from Clinical-pathological Specimens Using Touch Imprint Cytology

Published on: March 21, 2018

11.0K

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Healthcare
  • Genomics and Precision Medicine

Background:

  • Access to germline genetic testing is crucial for guiding cancer treatment and management.
  • The use of unstructured clinical notes presents a challenge for extracting this vital information.
  • Large language models (LLMs) offer a potential solution for automated data extraction.

Purpose of the Study:

  • To evaluate the performance of open-source, locally deployable LLMs in identifying germline genetic testing access among Veterans with breast cancer.
  • To compare the efficacy of different LLM models (Llama 3 70B, Llama 3 8B, Llama 2 70B) in this task.

Main Methods:

  • A cohort of 1,201 Veterans with breast cancer was identified within the VA system.
  • Clinical notes from a subset of 200 patients were reviewed by experts to establish ground truth.
  • LLM performance was assessed using accuracy, precision, recall, and F1 scores, with expert consensus as the benchmark.

Main Results:

  • Llama 3 70B achieved a high F1 score (0.912), significantly outperforming Llama 3 8B (0.811) and Llama 2 70B (0.644).
  • The performance of Llama 3 70B was comparable to that of individual expert reviewers.
  • LLM-identified access distribution across the cohort matched expert-identified distribution.

Conclusions:

  • Open-source, locally deployable LLMs can effectively and efficiently identify germline genetic testing access from clinical notes.
  • LLMs have the potential to enhance the quality and efficiency of cancer care.
  • The use of LLMs can aid in safeguarding sensitive patient data within healthcare systems.